Camptothecin is a DNA topoisomerase I inhibitor that blocks DNA synthesis and down-regulates THBS1 expression in human thyroid carcinoma FTC-133 cells through the JNK/ATF-2 pathway 79. The gene discussed is THBS1; the disease is thyroid gland carcinoma.